Advancing biotechnology with CRISPR/Cas9: recent applications and patent landscape
Open Access
- 24 January 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Industrial Microbiology and Biotechnology
- Vol. 45 (7) , 467-480
Abstract
Clustered regularly interspaced short palindromic repeats (CRISPR) is poised to become one of the key scientific discoveries of the twenty-first century. Originating from prokaryotic and archaeal immune systems to counter phage invasions, CRISPR-based applications have been tailored for manipulating a broad range of living organisms. From the different elucidated types of CRISPR mechanisms, the type II system adapted from Streptococcus pyogenes has been the most exploited as a tool for genome engineering and gene regulation. In this review, we describe the different applications of CRISPR/Cas9 technology in the industrial biotechnology field. Next, we detail the current status of the patent landscape, highlighting its exploitation through different companies, and conclude with future perspectives of this technology.Keywords
Funding Information
- Novo Nordisk UK Research Foundation
- Knut och Alice Wallenbergs Stiftelse
- Stiftelsen för Strategisk Forskning
This publication has 104 references indexed in Scilit:
- Control of gene expression by CRISPR-Cas systemsF1000Prime Reports, 2013
- Promoters maintain their relative activity levels under different growth conditionsMolecular Systems Biology, 2013
- Tunable and Multifunctional Eukaryotic Transcription Factors Based on CRISPR/CasACS Synthetic Biology, 2013
- RNA-Guided Human Genome Engineering via Cas9Science, 2013
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene ExpressionCell, 2013
- Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteriaProceedings of the National Academy of Sciences, 2012
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012
- The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coliNucleic Acids Research, 2011
- CRISPR interference: RNA-directed adaptive immunity in bacteria and archaeaNature Reviews Genetics, 2010